Drug
Prasterone
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Vaginal Discharge | 84 | 66.2 | 68.3 | signal |
| 2 | Poor Quality Product Administered | 45 | 34.7 | 35.3 | signal |
| 3 | Product Packaging Issue | 29 | 24.6 | 24.9 | signal |
| 4 | Product Administration Error | 57 | 22.5 | 22.9 | signal |
| 5 | Product Physical Issue | 51 | 20.1 | 20.5 | signal |
| 6 | Head Discomfort | 29 | 12.9 | 13.1 | signal |
| 7 | Photosensitivity Reaction | 27 | 12.9 | 13.0 | signal |
| 8 | Micturition Urgency | 17 | 11.8 | 11.9 | signal |
| 9 | Therapeutic Response Unexpected | 60 | 10.5 | 10.7 | signal |
| 10 | Arteriosclerosis | 11 | 9.2 | 9.2 | signal |
| 11 | Insurance Issue | 17 | 9.0 | 9.0 | signal |
| 12 | Vaginal Haemorrhage | 48 | 8.9 | 9.0 | signal |
| 13 | Seasonal Allergy | 15 | 8.3 | 8.4 | signal |
| 14 | Dermatitis Contact | 12 | 8.3 | 8.3 | signal |
| 15 | Infusion Site Pain | 12 | 7.4 | 7.4 | signal |
| 16 | Off Label Use | 793 | 7.2 | 9.8 | signal |
| 17 | Product Use Complaint | 14 | 7.1 | 7.1 | signal |
| 18 | Contraindicated Product Administered | 27 | 7.0 | 7.1 | signal |
| 19 | Brain Fog | 13 | 7.0 | 7.0 | signal |
| 20 | Tinnitus | 41 | 7.0 | 7.1 | signal |
| 21 | Poor Venous Access | 8 | 6.1 | 6.1 | signal |
| 22 | Restless Legs Syndrome | 14 | 6.0 | 6.1 | signal |
| 23 | Breast Pain | 8 | 5.9 | 5.9 | signal |
| 24 | Nocturia | 9 | 5.8 | 5.9 | signal |
| 25 | Hot Flush | 54 | 5.6 | 5.7 | signal |
| 26 | Pelvic Pain | 13 | 5.6 | 5.6 | signal |
| 27 | Night Sweats | 22 | 5.4 | 5.4 | signal |
| 28 | Lower Limb Fracture | 13 | 5.3 | 5.4 | signal |
| 29 | Sleep Apnoea Syndrome | 13 | 5.3 | 5.4 | signal |
| 30 | Deafness | 17 | 5.1 | 5.1 | signal |
| 31 | Tendon Rupture | 8 | 5.1 | 5.1 | signal |
| 32 | Underdose | 47 | 5.1 | 5.1 | signal |
| 33 | Fungal Infection | 21 | 5.0 | 5.0 | signal |
| 34 | Pharyngeal Swelling | 6 | 4.9 | 4.9 | signal |
| 35 | Cellulitis | 30 | 4.7 | 4.7 | signal |
| 36 | Feeling Hot | 36 | 4.6 | 4.7 | signal |
| 37 | Sinus Disorder | 11 | 4.4 | 4.4 | signal |
| 38 | Back Injury | 6 | 4.4 | 4.4 | signal |
| 39 | Application Site Pain | 12 | 4.3 | 4.3 | signal |
| 40 | Increased Tendency To Bruise | 5 | 4.3 | 4.3 | signal |
| 41 | Pollakiuria | 22 | 4.1 | 4.2 | signal |
| 42 | Ear Infection | 14 | 4.1 | 4.2 | signal |
| 43 | Feeling Jittery | 10 | 4.1 | 4.1 | signal |
| 44 | Drug Ineffective For Unapproved Indication | 29 | 4.1 | 4.1 | signal |
| 45 | Sinusitis | 53 | 4.0 | 4.1 | signal |
| 46 | Ligament Sprain | 5 | 4.0 | 4.0 | signal |
| 47 | Macular Degeneration | 6 | 4.0 | 4.0 | signal |
| 48 | Swelling Face | 32 | 3.9 | 3.9 | signal |
| 49 | Initial Insomnia | 5 | 3.9 | 3.9 | signal |
| 50 | Ear Discomfort | 5 | 3.8 | 3.8 | signal |
| 51 | Femur Fracture | 15 | 3.8 | 3.8 | signal |
| 52 | Ocular Discomfort | 5 | 3.6 | 3.6 | signal |
| 53 | Tooth Infection | 6 | 3.6 | 3.6 | signal |
| 54 | Heart Rate Increased | 45 | 3.6 | 3.6 | signal |
| 55 | Thyroid Disorder | 7 | 3.6 | 3.6 | signal |
| 56 | Illness | 45 | 3.5 | 3.6 | signal |
| 57 | Limb Injury | 12 | 3.5 | 3.5 | signal |
| 58 | Chromaturia | 10 | 3.5 | 3.5 | signal |
| 59 | Product Dose Omission Issue | 125 | 3.4 | 3.6 | signal |
| 60 | Discomfort | 26 | 3.4 | 3.4 | signal |
| 61 | Personality Change | 4 | 3.4 | 3.4 | signal |
| 62 | Carpal Tunnel Syndrome | 6 | 3.4 | 3.4 | signal |
| 63 | Spinal Operation | 5 | 3.2 | 3.2 | signal |
| 64 | Alopecia | 81 | 3.2 | 3.3 | signal |
| 65 | Mood Swings | 13 | 3.2 | 3.2 | signal |
| 66 | Inability To Afford Medication | 4 | 3.2 | 3.2 | signal |
| 67 | Disability | 8 | 3.2 | 3.2 | signal |
| 68 | Libido Decreased | 5 | 3.2 | 3.2 | signal |
| 69 | Intentional Dose Omission | 11 | 3.2 | 3.2 | signal |
| 70 | Dermatitis Allergic | 5 | 3.1 | 3.2 | signal |
| 71 | Injection Site Irritation | 5 | 3.1 | 3.1 | signal |
| 72 | Rotator Cuff Syndrome | 5 | 3.0 | 3.0 | signal |
| 73 | Burning Sensation | 27 | 3.0 | 3.0 | signal |
| 74 | Ankylosing Spondylitis | 5 | 3.0 | 3.0 | signal |
| 75 | Hypoacusis | 16 | 2.9 | 2.9 | signal |
| 76 | Fracture | 7 | 2.9 | 2.9 | signal |
| 77 | Pharyngitis Streptococcal | 4 | 2.9 | 2.9 | no signal |
| 78 | Inappropriate Schedule Of Product Administration | 64 | 2.8 | 2.9 | signal |
| 79 | Product Dose Omission | 23 | 2.7 | 2.7 | signal |
| 80 | Anger | 11 | 2.5 | 2.5 | signal |
| 81 | Application Site Irritation | 4 | 2.5 | 2.5 | no signal |
| 82 | Suicidal Ideation | 29 | 2.5 | 2.5 | signal |
| 83 | Drug Reaction With Eosinophilia And Systemic Symptoms | 8 | 2.5 | 2.5 | signal |
| 84 | Affect Lability | 3 | 2.4 | 2.4 | no signal |
| 85 | Drug Effective For Unapproved Indication | 9 | 2.4 | 2.4 | signal |
| 86 | Malignant Melanoma | 4 | 2.3 | 2.3 | no signal |
| 87 | Hunger | 4 | 2.3 | 2.3 | no signal |
| 88 | Eye Irritation | 16 | 2.3 | 2.3 | signal |
| 89 | Hereditary Angioedema | 3 | 2.2 | 2.2 | no signal |
| 90 | Product Packaging Quantity Issue | 3 | 2.2 | 2.2 | no signal |
| 91 | Product Availability Issue | 6 | 2.1 | 2.1 | no signal |
| 92 | Abnormal Weight Gain | 3 | 1.9 | 1.9 | no signal |
| 93 | Circumstance Or Information Capable Of Leading To Medication Error | 8 | 1.9 | 1.9 | no signal |
| 94 | Dysmenorrhoea | 3 | 1.8 | 1.8 | no signal |
| 95 | Acne | 17 | 1.8 | 1.8 | no signal |
| 96 | Hair Texture Abnormal | 3 | 1.7 | 1.7 | no signal |
| 97 | Therapeutic Response Shortened | 7 | 1.7 | 1.7 | no signal |
| 98 | Wrong Technique In Product Usage Process | 43 | 1.7 | 1.7 | no signal |
| 99 | Psoriatic Arthropathy | 8 | 1.6 | 1.6 | no signal |
| 100 | Premature Delivery | 3 | 1.5 | 1.5 | no signal |
| 101 | Exposure Via Skin Contact | 4 | 1.4 | 1.4 | no signal |
| 102 | Application Site Pruritus | 4 | 1.4 | 1.4 | no signal |
| 103 | Product Administered At Inappropriate Site | 3 | 1.3 | 1.3 | no signal |
| 104 | Injection Site Mass | 6 | 1.3 | 1.3 | no signal |
| 105 | Injection Site Pruritus | 10 | 1.2 | 1.2 | no signal |
| 106 | Injection Site Warmth | 3 | 1.1 | 1.1 | no signal |
| 107 | Device Leakage | 6 | 1.1 | 1.1 | no signal |
| 108 | Needle Issue | 4 | 1.1 | 1.1 | no signal |
| 109 | Injection Site Erythema | 15 | 1.0 | 1.0 | no signal |
| 110 | Product Complaint | 3 | 0.9 | 0.9 | no signal |
| 111 | Drug Abuse | 9 | 0.8 | 0.8 | no signal |
| 112 | Tardive Dyskinesia | 3 | 0.8 | 0.8 | no signal |
| 113 | Breast Cancer | 9 | 0.8 | 0.8 | no signal |
| 114 | Wrong Technique In Device Usage Process | 4 | 0.7 | 0.7 | no signal |
| 115 | Device Breakage | 3 | 0.6 | 0.6 | no signal |
| 116 | Device Difficult To Use | 4 | 0.5 | 0.5 | no signal |
| 117 | Drug Dose Omission By Device | 3 | 0.3 | 0.3 | no signal |